Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- Latest filing
- Nov 14, 2024
SNDX holding history
Syndax Pharmaceuticals Inc in every 13F filed by Ghost Tree Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNDX overviewAll 13F holders of SNDXFull Q3 2024 holdings
- Shares (Q3 2024)
- 450,000
- Value
- $8.66M
- % of portfolio
- 3.0%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 450,000 | $8.66M | 3.0% | +100,000+28.6% | Added | Holders |
| Q2 2024 | 350,000 | $7.19M | 2.5% | +200,000+133.3% | Added | Holders |
| Q1 2024 | 150,000 | $3.57M | 1.1% | +150,000 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −200,000−100.0% | Sold out | Holders |
| Q3 2023 | 200,000 | $2.90M | 1.4% | −150,000−42.9% | Reduced | Holders |
| Q2 2023 | 350,000 | $7.33M | 2.6% | +25,000+7.7% | Added | Holders |
| Q1 2023 | 325,000 | $6.86M | 2.6% | +175,000+116.7% | Added | Holders |
| Q4 2022 | 150,000 | $3.82M | 1.6% | −50,000−25.0% | Reduced | Holders |
| Q3 2022 | 200,000 | $4.81M | 2.0% | −25,000−11.1% | Reduced | Holders |
| Q2 2022 | 225,000 | $4.33M | 3.0% | 00.0% | Unchanged | Holders |
| Q1 2022 | 225,000 | $3.91M | 1.9% | −75,000−25.0% | Reduced | Holders |
| Q4 2021 | 300,000 | $6.57M | 2.5% | −275,000−47.8% | Reduced | Holders |
| Q3 2021 | 575,000 | $11.0M | 3.6% | −300,000−34.3% | Reduced | Holders |
| Q2 2021 | 875,000 | $15.0M | 4.7% | −300,000−25.5% | Reduced | Holders |
| Q1 2021 | 1,175,000 | $26.3M | 7.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.